Zsolt Gabos

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Oncology Dept

Email: zgabos@ualberta.ca
Phone: (780) 432-8783

Overview

Area of Study / Keywords

About

Clinical Interests
Breast and lung malignancies, Peripheral Radiation Oncology Clinic in Red Deer

Research

Zsolt Gabos' research interests include advanced treatment delivery techniques in breast cancer, image guided radiotherapy and stereotactic body radiotherapy for the treatment of lung cancer. He is the breast tumour group leader in radiation oncology for the North Alberta Breast Care Program”

Featured Publications

Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial

Abraham A., Sanghera K.P., Gheisari F., Koumna S., Riauka T., Ghosh S., Warkentin H., Gabos Z., Chafe S., Tankel K., Huang F., Sabri S., Paterson D.I., Abdulkarim B., Joseph K.

International Journal of Radiation Oncology Biology Physics. 2022 May; 113 (1):125-134 10.1016/j.ijrobp.2022.01.020

DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial

Hugh J.C., Haddon L.S.J., Githaka J.M., Bigras G., Hu X., Madden B., Hanson J., Gabos Z., Giannakopoulos N.V., Huang F., Hitt M.M., McManus K.J., Olson D., Dabbs K., Mackey J.R.

Heliyon. 2021 December; 8 (1):e08666 10.1016/j.heliyon.2021.e08666

Time domain principal component analysis for rapid, real-time 2D MRI reconstruction from undersampled data

Wright M., Dietz B., Yip E., Yun J., Gabos Z., Fallone B.G., Wachowicz K.

Medical Physics. 2021 November; 48 (11):6724-6739 10.1002/mp.15238

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial

Sahgal A., Myrehaug S.D., Siva S., Masucci G.L., Maralani P.J., Brundage M., Butler J., Chow E., Fehlings M.G., Foote M., Gabos Z., Greenspoon J., Kerba M., Lee Y., Liu M., Liu S.K., Thibault I., Wong R.K., Hum M., Ding K., Parulekar W.R.

The Lancet Oncology. 2021 July; 22 (7):1023-1033 10.1016/S1470-2045(21)00196-0

Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study

Joseph K., Zebak S., Alba V., Mah K., Au C., Vos L., Ghosh S., Abraham A., Chafe S., Wiebe E., Liu H.W., Chambers C., Gabos Z., Tankel K., Lupichuk S., King K.

Radiotherapy and Oncology. 2021 January; 154 10.1016/j.radonc.2020.09.017

Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial

Joseph K., Vos L.J., Gabos Z., Pervez N., Chafe S., Tankel K., Warkentin H., Ghosh S., Amanie J., Powell K., Polkosnik L.A., Horsman S., MacKenzie M., Sabri S., Parliament M.B., Mackey J., Abdulkarim B.

Clinical Oncology. 2021 January; 33 (1):30-39 10.1016/j.clon.2020.07.005

5 year longitudinal analysis of myocardial perfusion scintigraphy post radiotherapy using single-photon emission computed tomography (SPECT). Results from a phase III study

2020 ASTRO. 2020 October;

CCTG SC.24/RTOG 17.06: A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractoins versus 20 Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases.

ASTRO. 2020 October;